European Case Law Identifier: | ECLI:EP:BA:1997:T052994.19971009 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 09 October 1997 | ||||||||
Case number: | T 0529/94 | ||||||||
Application number: | 87300248.9 | ||||||||
IPC class: | A61K 9/10 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Fluorocarbon blood substitutes | ||||||||
Applicant name: | ALLIANCE PHARMACEUTICAL CORP. | ||||||||
Opponent name: | - | ||||||||
Board: | 3.3.02 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Amendments (yes) - late submitted amendments disclosed in the filed application Procedural violation (no) - sufficient reasons to exercise the discretion provided for by Rule 86(3) Second oral proceedings correctly denied |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t940529eu1.html
Date retrieved: 17 May 2021